The purpose of this study is to evaluate the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with the Alterra Adaptive Prestent, which is approved by ...
Primary Objective:
To evaluate the effect of CK-3773274 on exercise capacity in patients with symptomatic oHCM.
Secondary Objectives:
1. To evaluate the effect of CK-3773274 on patient health status
2. ...
The purpose of this study is to determine whether an investigational drug called NNC6019-0001 can be used to treat people with transthyretin (TTR) amyloid cardiomyopathy, a heart disease due to ...
The objective of the study is to assess the long-term safety of patisiran in patients with ATTR amyloidosis with cardiomyopathy as assessed by a review of adverse events (AEs).
